Antibiotic irrigation and conservative for major aortic graft infection

Size: px
Start display at page:

Download "Antibiotic irrigation and conservative for major aortic graft infection"

Transcription

1 Antibiotic irrigation and conservative for major aortic graft infection surgery G. E. Morris, DM, MCh, FRCS, P. J. Friend, MA, FRCS, D. J. Vassallo, FRCS, RAMC, M. Farrington, MA, MRCPath, S. Leapman, MD, FACS, and C. R. G. Quick, MS, FRCS, Cambridge, London, and Huntingdon, United Kingdom and Indianapolis, Ind. Purpose: Traditional surgical treatment for panprosthetic aortic graft infection entails radical excision of the graft, aortic stump closure, and extraanatomic revascularization of the lower limbs. This carries an early mortality rate of 24% to 45%. Amputation rates range from 11% to 37%. Multiple operations and prolonged hospital stay are usual. We have developed a more conservative management technique with the aim of improving outcome. Methods: We describe an innovative method of treating the condition with prolonged, high-dose, local antibiotic irrigation therapy, systemic antibiotic treatment, surgical debridement, and graft conservation in a prospectively studied series of 10 patients. Results: The actual 30-day patient survival rate is 90%, the 1-year survival rate is 80%, and the 4-year survival rate is 67%. Two patients died because of graft infection, and the third died, uninfected, of an unrelated cause. No limbs have been amputated. Only two patients required a second operation. Mean postoperative hospital stay was 32 days. The seven survivors have been closely followed up with regular computed tomography or indium scanning and clinical examination and appear to be free from infection at a mean of 61 months after cessation of irrigation therapy. Conclusion: The technique appears to represent a significant improvement in the management of this major complication of vascular surgery. (J VASC SURG 1994;20:88-95.) The most feared complication of vascular surgery is prosthetic graft infection. Overall rates for major aortic graft infection average approximately 2%, ranging from less than 1% to 6% in published series. 16 If an abdominal aortic prosthesis is involved, traditional teaching dictates removal of the infected graft, oversewing of the aortic stump, and, since the introduction of the technique in 1963, insertion of an extraanatomic bypass. 5,712 This management is technically complex and carries a reported early mortality rate of 24% to 45%. 132 Despite this, it From the Department of Surgery (Messrs. Morris, Friend, and Quick), Clinical Microbiology and Public Health Laboratory (Dr. Farrington), Cambridge, the Department of Surgery (Mr. Vassallo), Royal Army Medical College, Millbank, London, Transplant Unit (Dr. Leapman), University Hospital, Indianapolis, and Department of Surgery (Mr. Quick), Hinchingbrooke Hospital, Huntingdon. Reprint requests: C. R. G. Quick, MS, FRCS, Department of Surgery, Hinchingbrooke Hospital, Hinchingbrooke Park, Huntingdon, Cambs, PE18 8NT, United Kingdom. Copyright 1994 by The Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter /94/$ /1/ remains the conventional surgical solution for major graft infections. 21 In an effort to reduce the morbidity and mortality rates of the condition, we have devised a simpler, more conservative method of treatment. 22 Patients with infected aortic grafts are treated by surgical drainage, antibiotic irrigation of the graft and systemic antibiotic therapy without graft removal. Encouraged by the short-term (2- to 3-year follow-up) results of this technique in four cases reported in 1990, we now present a larger series of patients with medium- to long-term follow-up. PATIENTS AND METHODS This study reports the treatment of 10 patients who have been treated for major aortic graft infections from 1985 to Table i gives the details of these cases. Anastomoses were within the infected fields in nine cases, all anastomoses were involved in four grafts, and a single anastomosis was involved in five grafts. It is important to note that suture-line integrity was preserved on all occasions. All grafts were found at surgery to be lying in gastrointestinal contents or frank pus.

2 Volume 20, Number 1 J]/lorris et al. 89 Table I. Patient and graft details Patient Age Graft type Complicating factors Time to infection Extent of infection 1 59 Aortoiliac (aneurysm) Replacement graft for 3 anastomotic 81 days Whole graft false aneurysms after aortoiliac aneurysm repair, duodenal damage 2 72 Aortoiliac (aneurysm) Colon erosion by aneurysm, synchro- 70 days Limb graft (L) nous colectomy 3 52 Aorta (aneurysm) Past UTI and septicemia, traumatic 31 days Whole graft catheterization 4 67 Aortobifemoral (aneurysm) Ruptured AAA, adhesions from pre- 18 days Limb graft (L) vious peritonitis, cecal perforation 5 40 Redo (R) limb aortobifemoral Redo for graft occlusion, adhesions 28 days Limb graft (R) 6 81 Aorta (aneurysm) Ruptured AAA, diverticulitis, large 30 days Whole graft hematoma 7 45 Aortoifiac (aneurysm) Established end-stage renal failure 26 days Limb graft (L) 8 63 Aortobifemoral (aneurysm) Ligation IMA, ischemic colon, colos- 94 days Proximal graft tomy, Hartmann's 9 74 Aorto(R)femoral (aneurysm) Ruptured AAA, absent (R) femoral 926 days Distal aortic graft pulse, A-F graft Aortoiliac (aneurysm) Redo distal false aneurysm after 15 days Whole graft ruptured AAA repair, ischemic colon, fecal peritonitis, Hartmann's operation UT/, Urinary tract infection; AAA, abdominal aortic aneurysm; A-F, aortofemoral; L, left; R, right. These patients had previously undergone major aortic reconstructions, all of which were complicated. Three were repeat reconstructions, three were emergency operations for ruptured abdominal aortic aneurysms, and the others were at increased risk of graft infection for various reasons detailed in Table I. In five cases the graft was contaminated directly by gastrointestinal contents. Infection in nine of the 10 grafts became apparent within a few months of operation (mean 4.4 months, range 0.5 to 31 months). The diagnosis of graft infection was made by computed tomography (CT) scanning alone in four cases, ultrasonography alone in one case, indiumlabeled white blood cell scanning combined with CT scanning or ultrasonography in three cases, and by clinical evidence alone in two cases. The typical findings were as reported in the literature: on CT scanning, perigraft fluid and gas; on ultrasonography, perigraft fluid; and on indium-labeled white blood cell scanning, markedly increased uptake in the region of the grafts. 21'2s26 After our early experience of the irrigation technique reported in 1990, 22 we have devised a standardized protocol for treating these cases: (1) The infected graft is exposed by use of an extraperitoneal approach, if feasible. The sac is opened, and all pus and nonviable tissue are removed. (2) Samples of pus and tissue are obtained for microbiologic culture, and the graft is thoroughly irrigated with normal saline solution. (3) Two to four silicone tube drains (5 mm suggested), with multiple side holes cut in them, are placed inside the sac along the limb(s) of the graft, an end directed toward each anastomosis. The tubes are then brought out via the extraperitoneal plane to exit the skin in the loin. The native sac is closed over the graft if possible (See Fig. 1). (4) The tubes are irrigated in rotation as follows: 20 mg gentamicin in 20 ml saline solution every 2 hours for the first 12 hours; Irrigation with the same dose and volume every 4 hours for the next 12 hours; A precautionary serum gentamicin assay is performed after 24 hours; If the measured serum concentration is less than 5 mg/l, irrigation continues with 20 mg gentamicin in 20 ml saline solution every 6 hours. If it is greater than 5 mg/l, the gentamicin dose is reduced (although we have never found this to be necessary). (5) Concurrently, intravenous gentamicin (80 to 120 mg once daily), penicillin (1 megaunit four times daily), and metronidazole (500 mg three times daily) are administered. (6) Gentamicin levels are assayed three times a week at times related to systemic administration. Predose concentrations are maintained below 2 mg/l and peak concentrations (60 minutes after the dose) between 4 to 6 mg/l, by adjusting the single intravenous dose. (7) Regular cultures of the drain effluent are made, and the antibiotic regimen is changed according to sensitivities of the pathogens isolated. (8) Irrigation is continued until three consecutive effluent cultures are sterile or as prompted by other events, such as isolation of Candida albicam from the effluent. (7)

3 90 3/lorris et al. JOURNAL OF VASCULAR SURGERY ]tdy 1994 Fig. 1. Technique for irrigation of infected graft. Three 5 mm silicone drainage tubes are placed to lie between native aneurysm sac and prosthesis, each directed toward anastomosis. For nonbifurcated prostheses, two tubes are used. Tubes enter via arteriotomy in sac, which is sutured snugly around tubes with absorbable sutures. Each tube has several side holes cut in part that lies inside sac. Drains are removed sequentially. (8) Most patients have been maintained on oral antibiotics for several weeks or months. The duration of this therapy has not been formalized. Table II shows the details of the treatment schedules for all patients in this series. Deviations from the developing protocol have occurred and will be discussed. RESULTS A summary of the results of this series of irrigation therapy for major graft infections is shown in Table III. Actual survival rates for the series are 90% at 30 days, 80% at 1 year, and 67% at 4 years. Two patients died as a result of their graft infections, and the third died at 10 months of a myocardial infarct, with the graft proven to be uninfected at postmortem examination. There have been no amputations performed in the series. Only two patients have required a second operation (one for an ischemic colostomy and one for a displaced irrigation catheter). The mean postoperative stay was 32 days (range 21 to 66 days). The mean follow-up for the seven survivors is 61 months after cessation of irrigation (range 17 to 84 months, as of September 1993). All survivors have been closely reviewed as outpatients and have tradergone regular CT or indium scanning to confirm absence of infection. Gentamicin was used as the first-fine irrigation antibiotic in six cases in this series, clavulanate potassium-potentiated amoxicillin in three and clindamycin in one. Irrigation therapy with multiple antibiotics was used in four cases, the other agents being penicillin, metronidazole, or cefotaxime. The duration of irrigation therapy was a mean of 23 days, with a range of 12 to 56 days. Concurrent multiple intravenous antibiotic therapy was administered in nine cases for a mean of 20 days, range 9 to 35 days. Longer term oral administration was continued in six patients (one indefinitely). In case 10, Enterococcusfaecalis highly resistant to gentamicin (no zone to a 100 ~g gentamicin disc)

4 Volume 20, Number 1 x~ioryis et al. 91 was isolated from the effluent fluid throughout the first 10 days of irrigation with gentamicin. This patient was also receiving intravenous metronidazole, penicillin, and gentamicin, and had previously been treated with parenteral gentamicin. At day 14, penicillin (1 megaunit three times daily) was substituted as the irrigation antibiotic and the intravenous antibiotics were replaced by oral ciprofloxacin, amoxicillin, and metronidazole. Drainage cultures became sterile after 9 days of this regimen, which was continued for a total of 13 days. Cultures taken at the time of placement of the irrigation tube drains in case 1 grew Escherichia coli, but C. albicans was isolated in heavy growth from the drainage effluent 1 day later. Amphotericin B was therefore added to both the irrigation (20 mg per day) and intravenous (20 mg per day) regimens. Effluent cultures continued to grow C. albicans for 10 days, but irrigation and intravenous therapy was stopped 3 days later, and the patient made a good recovery, with no evidence of persistent fungal infection. Irrigation therapy was unsuccessful in two patients, but both had complicating factors: Case 2 was admitted 70 days after undergoing aortoiliac bypass grafting and sigmoid colectomy with a fistula be tween the colonic anastomosis and the aortoiliac graft-the procedures were undertaken to repair a false aneurysm eroding the sigmoid colon after an iliac endarterectomy and Dacron inlay patch carried out 7 years before. After irrigation therapy the patient recovered well and remained free from graft infection for 27 months. He was readmitted with the symptoms and signs of recurrent graft infection, but he had recently had a major myocardial infarct, so was not fit for surgical intervention. Without this complicating factor, further lavage and irrigation therapy would have been possible. He continued to deteriorate and died a few days later. Case 6 had undergone repair of a ruptured abdominal aortic aneurysm 1 month previously, at which sigmoid diverticular disease was noted. He was admitted with an established graft infection, diagnosed by plain abdominal radiography (air outlining the graft) and CT scanning. 27 The graft was explored, and drains were placed. However, the drains became displaced, rendering treatment ineffective, and a further drain was placed on the nineteenth day of treatment. Two days later the patient died of a secondary hemorrhage. This patient was believed to have ongoing sepsis caused by a persistent large bowel fistula, and his treatment had failed to irrigate the graft adequately. One patient (case 7) with chronic kidney failure caused by polycystic disease underwent successful kidney transplantation 1 year after treatment. He remains well with good renal function and is free from recurrent infection more than 4 years later, despite immunosuppressive therapy. Another patient (case 3) underwent emergency coronary artery bypass grafting and aortic root replacement 5 years after treatment and remains well and free from infection 2 years later. Another patient (case 8) had an uncomplicated vein bypass of a popliteal aneurysm 1 year after treatment and is also well and free from infection 4 years later. DISCUSSION This is the first reported series of successful conservative management of aortic grafts extensively infected by enteric organisms with medium- to long-term follow-up. Its success has confirmed the encouraging short-term results published in our earlier report. 22 Conventional treatment of major aortic graft infection is by graft removal and extraanatomic bypass. Many attempts have been made to reduce the considerable morbidity and mortality rates of this procedure. Successful graft excision, debridement, and in situ replacement with a mortality rate as low as 17% was reported by Walker et al.28 However, a later series from the same unit presented less optimistic results, with a mortality rate of 83% in severe graft infections. 29 The major causes of death were recurrent sepsis and secondary hemorrhage. Prolonged hospital stay (Lorentzen et ai.4 reported a mean of 90 days), multiple operations (1.4 to 2.6), and high amputation rates (11% to 37%) are all sequelae of conventional treatment. 2-5,2,s One alternative technique to improve outcome involves placing gentamicin beads in the infected field or adjacent to the graft for i to 2 weeks. This method has been described in small series and isolated case reports in combination with graft excision to lower the risk of aortic stump blowout, and as a conservative method of treating localized groin infections. 31,32 The technique is substantially less successful as a conservative treatment of more extensive aortic graft infections. 33 Irrigation with antibiotics and antiseptics has been well described in the successful treatment of deep-seated infections in orthopedic surgery. 34 The technique has been adapted for the treatment of vascular graft infections. Kesults of a number of small series have been generally encouraging, but only for very limited infections of vascular grafts, particu-

5 92 Morris et al. July 1994 Table II. Microbiology and treatment Patient Drain/irrigation tubes Culture result at tube placement (& during irrigation) Antibiotics Irrigation Duration 1 3 x 5 mm silicone mm silicone, gentamicin beads mm silicone 4 3 x 5 mm silicone mm silicone mm silicone 7 1 x 5 mm silicone 8 3 x 5 mm silicone 9 2 x 5 mm silicone 1 x 15 mm silicone 10 3 x 5 mm silicone E. coli (C. albicans) (Citroba~ter sp.) I~bsiella sp. Proteus mirabilis S. faecalis E. coli E. coli S. faecalis, E. coli, Bacteroides sp. Clostridium sp. Proteus sp. Bacteroides sp. S. faecalis, E. coli (Peptog.OCCUS) Bacteroides fragilis (Candida albicam) S. faecalis, Enterobacter cloacae, B. fragilis (HLGR Enterococcus faecalis) Gentamicin, penicillin Amphotericin Augmentin Augmentin, cefotaxime Penicillin, gentamicin Augmentin Gentamicin, metronidazole, ampicillin Clindamycin Gentamicin Gentamicin Gentamicin, penicillin 14 days 13 days 20 days 39 days 16 days 56 days 12 days 18 days 18 days 12 days 14 days 13 days HLGR, High level gentamicin resistant (resistant to a 100 ~g gentamicin disc). larly those involving staphylococcal infections of groin incisions and the underlying prosthetic graft limbs, sss9 Experience of irrigation therapy with antibiotics/antiseptics in panprosthetic infections is extremely limited, with single case reports forming the basis of the literature. *,41 The results of our series are better than those quoted for traditional graft excision, and the method is considerably less demanding technically. No limbs have been lost, and multiple operations have been avoided. Hospital stay has been kept to a minimum. Although detailed costings are not available for patients from the British National Health Service, the technique appears to offer substantial economic benefits. Six of the seven survivors remain clinically (and on CT evidence) free of infection at 4 to 7 years after treatment. These patients fulfil the criteria of an assumed cure attributed to Szilagyi et al.2_ freedom from infection at 2 years. Szilagyi et al., however, also noted that in rare instances an apparently cured infection may flare up at a much later stage. Most of our patients had received parenteral antibiotic therapy before the operation to place the irrigation tube drains was performed. Because of the frequent involvement of colonic flora in major aortic graft infection, and concerns over the renal function of these patients, this prior therapy frequently included a broad-spectrum cephalosporin plus metronidazole. In four cases operative cultures grew enterococci, which are naturally resistant to cephalosporins. The combination of penicillin, gentamicin, and metronidazole for treatment of our latter patients was chosen primarily to treat enterococci, and also to cover the possible involvement of cephalosporinresistant coliforms. Intravenous penicillin can bc given in large doses and has good tissue penetration, but if applied locally is likely to cause sensitization. 42 Gentamicin is potentially toxic if prolonged, highlevel systemic treatment is required. Furthermore, [3-1actams and gentamicin may mutually inactivate if mixed in solution. 43 For these reasons, we have now standardized a regimen of penicillin given parenterally in high dose, and gentamicin by irrigation with a single daily intravenous dose to achieve therapeutic systemic, and high local concentrations. Serum gentamicin assay was performed three times weekly immediately before and 1 hour after these daily doses. Predose serum concentrations were maintained below 2 mg/l, and peak concentrations between 4 and 6 mg/l by adjusting the intravenous dose. No patient treated with this regimen had apparent deterioration in renal function as measured by serum urea or creatinine concentrations. The decision to cease irrigation therapy, and remove the tube drains, has necessarily been in part arbitrary, but we now recommend a period of irrigation of at least 14 days. Monitoring leucocyte counts and the erythrocyte sedimentation rate is an unreliable guide, because we have found these often only return to normal after several weeks of treatment, significantly after the drains are removed.

6 Volume 20, Number 1 Morris et al. 93 Parenteral Oral Antibiotics Duration Antibiotics Duration Amphotericin 13 days Cefuroxime, metronidazole i dose Cefbtaxime, gentamicin 35 days Augmentin Indefinite Penicillin, gentamicin 18 days - - Piperacillin, cefuroxime 21 days Augmentin 20 months Gentamicin, metronidazole 9 days - Vancomycin, imipenem, amikacin Ampicillin, gentarnicin 18 days 28 days Metronidazole Amoxicillin 3 months 1 month Gentamicin, penicillin, metronidazole 14 days Metronidazole 6 days Gentamicin, penicillin, metronidazole 14 days Metronidazole, amoxicillin, ciprofloxacin 4 months Table IlL Outcome Latest figllow-up Patient Status Cause of death graft status Follow-up investigations Duration Comment I Dead Myocardial infarction Uninfected at PM CF scanning 10 months 2 Dead Sepsis Graft reinfected CT scanning 27 months Recent myocardial infarction, unfit for surgery 3 Alive Patent, uninfected Annual CT scanning, 84 months indium scanning 4 Alive Patent, uninfected Annual CT scanning 70 months 5 Alive R limb occluded and Indium scanning 77 months excised, uninfected 6 Dead Secondary hemorrhage Graft infected CT scanning 21 days 7 Alive Patent, uninfected Annual C1 ~ scanning, 64 months Indium scanning 8 Alive Patent, uninfected Annual C'F scanning 59 months 9 Alive Patent, uninfected Annual CT scanning 53 months 10 Alive Patent, uninfected CT scanning 17 months PM, Postmortem examination; R, right. Drains displaced, inadequate therapy Kidney transplant after 11 months Indications to switch to oral continuation therapy include three sterile consecutive daily effluent cultures, and isolation of Candida sp. We suspect that late isolation of yeasts represents distal colonization of the drains, which should therefore be removed to prevent subsequent deep infection of the graft. C. albicans was grown from the drainage effluent of case i in heavy growth from the first postoperative day. Fungal infections of arterial prostheses are rare, but have previously been reported to carry a grave mortality rate unless the graft is excised with extraanatomic bypass, and 6 to 8 weeks of intravenous amphotericin B is given. 44 Combined irrigation and intravenous therapy with amphotericin B for 2 weeks was successful in case 1. Thus this technique appears to be effective in fungal and bacterial infections. Enterococci are recognized as important causes of aortic graft infection. 4 High-level (resistant to a 100 ~g gentamicin disc) aminoglycoside resistant fecal streptococci are an increasing nosocomial infection problem, and are resistant to synergistic killing by penicillin plus gentamicin. 4s Patient 10 remains free of infection 16 months after irrigation with penicillin (given, despite the theoretic risk of sensitization, to achieve exceptionally high local concentrations) and

7 lour2q~ OF VASCULAR SURGERY 94 IVlorris et al. July 1994 prolonged oral therapy with amoxicillin and ciprofloxacin. Our experience of this technique is mainly limited to early infections, but we suggest it has a place in the treatment of both early and late panprosthetic graft infections with anastomotic involvement, providing suture line integrity is preserved. We have no experience of the technique if disruption has occurred. Some form of more radical combination treatment is obviously required in these cases. Minor peripheral graft infections may be treated by this method or other previously described conservative techniques. Additionally, our experience suggests that a number of factors are of vital importance: correct drain placement is essential, and positions should be checked by contrast studies if in doubt. Effluent fluid should be cultured regularly, with antibiotic therapy adjusted according to the results without delay, and possible overgrowth of yeasts monitored. In conclusion, this method of treatment, in appropriate cases, appears to offer the dual advantages of a superior outcome in terms of infection-free survival and limb loss, while requiring a single, less hazardous surgical procedure for a critically ill patient. We believe that the technique may represent a significant improvement in the management of this major complication of vascular surgery. Clearly the number of patients presented is small, but we believe that the results reported here warrant further investigation in a larger scale multicenter study. The following surgeons (in addition to the authors) and centers have participated in this series: Professor Sir Roy Calne, Addenbrooke's Hospital, Cambridge, U.K.; Mr. J. F. Colin, Norfolk and Norwich Hospital, Norwich, U.K.; Mr. J. A. Dormandy, St. George's Hospital, London, U.K.; Mr. R. M. Heddle, Kent and Canterbury Hospital, Canterbury, U.K. REFERENCES 1. Hoffert PW, Gensler S, Haimovici H. Infection complicating arterial grafts. Arch Surg 1965;90: Szilagyi DE, Smith RF, Elliott JP, Vrandecic MP. Infection in arterial reconstruction with synthetic grafts. Ann Surg 1972; 176: Goldstone J, Moore WS. Infection in vascular prostheses: clinical manifestations and surgical management. Am J Surg 1974;128: Lorentzen JE, Nielsen OM, Arendrup H, et al. Vascular graft infection: an analysis of sixty-two graft infections in 2411 consecutively implanted synthetic vascular grafts. Surgery 1985;98: O'Hara PJ, Hertzer NR, Beven EG, Krajewski LP. Surgical management of infected abdominal aortic grafts: review of a 25-year experience. J VAsc SURG 1986;3: Earnshaw JJ. Infection after vascular reconstruction-hard graft for surgeons. Surg Infect 1991;3: BlaisdeU FW, Hall AD. Axillary-femoral artery bypass for lower extremity ischemia. Surgery 1963 ;54: Louw JH. Splenic-to-femoral and axillary-to-femoral bypass grafts in diffuse atherosclerotic occlusive disease. Lancet 1963;I: Conn JH, Hardy JD, Chavez CM, Fain WR. Infected arterial grafts: experience in 22 cases with emphasis on unusual bacteria and technics. Ann Surg 1970;171: Trout HH, Kozloff L, Giordano JM. Priority of revascularization in patients with graft enteric fistulas, infected arteries, or infected arterial prostheses. Ann Surg 1984;199: Yeager RA, McConneU DB, Sasaki TM, Vetto RM. Aortic and peripheral prosthetic graft infection: differential management and causes of mortality. Am J Surg 1985;150: Goldstone J. The infected infra-renal aortic graft. Acta Clair Scand Suppl 1987;538: Jamieson GG, DeWeese JA, Rob CG. Infected arterial grafts. Ann Surg 1975;181: Spanos PK, Gilsdorf RB, Sako Y, Najarian JS. The management of infected abdominal aortic grafts and graft-enteric fistulas. Ann Surg 1976;183: Liekweg WJ, Greenfield LJ. Vascular prosthetic infections: collected experience and results of treatment. Surgery 1977; 81: Comfier JM, Ward AS, Lagneau P, Janneau D. Infection complicating aortoiliac surgery. J Cardiovasc Surg (Torino) 1980;21: Casali RE, Tucker WE, Thompson BW, Read RC. Infected prosthetic grafts. Arch Surg 1980;115: Downs AR, Lye CR, MacKean G. Graft infections in aortoiliac arterial reconstructions. Can J Surg 1983;26: , Ricotta J}', Faggioli GL, Stella A, et al. Total excision and extra-anatomic bypass for aortic graft infection. Am J Surg 1991;162: Quifiones BW, Hernandez JJ, Moore WS. Long-term results following surgical management of aortic graft infection. Arch Surg 1991;126: O'Brien T, Coffin J. Prosthetic vascular graft infection. Br J Surg 1992;79: Quick CR, Vassallo DJ, Colin JF, Heddle RM. Conservative treatment of major aortic graft infection. Eur J Vasc Surg 1990;4: Haaga JR, Baldwin GN, Reich NE, et al. CT detection of infected synthetic grafts: preliminary report of a new sign. AJR Am J Roentgenol 1978;131: Stevick CA, Fawcett HD. Aortoiliac-graft infection: detection by leukocyte scan. Arch Surg 1981;116: Mark A, Moss AA, Lusby R, Kaiser IA. CT evaluation of complications of abdominal aortic surgery. Radiology 1982; 145: Lawrence PF, Dries DJ, Alazraki N, Albo DJ. Indium 1 l l-labeled leukocyte scanning for detection of prosthetic vascular graft infection. J VASC SURG 1985;2: Wright IF, VassaUo DJ, Dundas DD. The aortic pole. Br J Radiol 1988;61: Walker WE, Cooley DA, Duncan JM, Hallman GJ, Ott DA, Reul GJ. The management of aortoduodenal fistula by in situ replacement of the infected abdominal aortic graft. Ann Surg 1987;205: Jacobs MJ, Reul GJ, Gregoric I, Cooley DA. In-situ replace-

8 Volume 20, Number 1 Morris et al. 95 ment and extra-anatomic bypass for the treatment of infected abdominal aortic grafts. Eur J Vasc Surg 1991;5: Reilly LM, Stoney RJ, Goldstone J, Ehrenfeld WK. Improved management of aortic graft infection: the influence of operation sequence and staging. J VASC SURG 1987;5: Bailey IS, Bundred NJ, Pearson HJ, Bell PR. Successful treatment of an infected vascular graft with gentamicin beads. Eur J Vasc Surg 1987;1: Reilly DT, Grigg MJ, Mansfield AO. Intraperitoneal placement of gentamicin beads in the management of prosthetic graft sepsis. J R Coil Surg Edinb 1989;34: Nielsen OM, Noer HH, Jorgensen LG, Lorentzen JE. Gentamycin beads in the treatment of localised vascular graft infection--long term results in 17 cases. Eur J Vasc Surg 1991;5: Kawashima M, Torisu T, Kamo Y, Iwabuchi A. The treatment of pyogenic bone and joint infections by closed irrigationsuction. Clin Orthop 1980;148: Popovsky J, Singer S. Infected prosthetic grafts. Local therapy with graft preservation. Arch Surg 1980;115: Almgren B, Eriksson I. Local antibiotic irrigation in the treatment of arterial graft infections. Acta Chir Scand 1981;147: Kwaan JH, Connolly JE. Successful management of prosthetic graft infection with continuous povidone-iodine irrigation. Arch Surg 1981;116: Edwards MJ, Richardson JD, Klamer TW. Management of aortic prosthetic infections. Am J Surg 1988;155: Moran KT, Jewell ER. Local antiseptic treatment of infected prosthetic vascular grafts in the groin. Br J Surg 1988;75: Knight CJ, Famell MB, Hollier LH. Treatment of aortic graft infection with povidone-iodine irrigation. Mayo Clin Proc 1983;58: Francois F, Thevenet A. Conservative treatment of prosthetic aortic graft infection with irrigation. Ann Vasc Surg 1991; 5: Lambert HI', O'Grady FW. Peulcillins. In: Antibiotic and Chemotherapy. 6th ed. Edinburgh: Churchill Livingstone, 1992: Wallace SM, Chan LY. In vitro interaction ofaminoglycosides with beta-lactarn penicillins. Antimicrob Agents Chemother 1985;28: Doscher W, Krishnasastry KV, Deckoff SL. Fungal graft infections: case report and review of the literature. J VAsc SURG 1987;6: Murray BE. The life and times of the enterococcus. Clin Microbiol Rev 1990;3: Submitted Sept. 28, 1993; accepted Dec, 28, 1993.

Use of antibiotic-loaded polymethylmethacrylate beads for the treatment of extracavitary prosthetic vascular graft infections

Use of antibiotic-loaded polymethylmethacrylate beads for the treatment of extracavitary prosthetic vascular graft infections From the Society for Clinical Vascular Surgery Use of antibiotic-loaded polymethylmethacrylate beads for the treatment of extracavitary prosthetic vascular graft infections Patrick A. Stone, MD, Paul A.

More information

Prosthetic Vascular Graft Infection

Prosthetic Vascular Graft Infection Prosthetic Vascular Graft Infection Charito Love, MD Division of Nuclear Medicine & Molecular Imaging North Shore Long Island Jewish Health System Manhasset & New Hyde Park, New York Prosthetic Vascular

More information

Fungal graft infections: Case report and review of the literature

Fungal graft infections: Case report and review of the literature Fungal graft infections: Case report and review of the literature William Doscher, M.D., K. V. IC, a-ishnasastry, M.D., and Stephen L. Deckoff, M.D., Flushing, N.Y. Fungal intravascular graft infections

More information

A Coordinated Registry Network Based on the Vascular Quality Initiative: VISION. Vascular Implant Surveillance & Interventional Outcomes Network

A Coordinated Registry Network Based on the Vascular Quality Initiative: VISION. Vascular Implant Surveillance & Interventional Outcomes Network A Coordinated Registry Network Based on the Vascular Quality Initiative: VISION Vascular Implant Surveillance & Interventional Outcomes Network Jack L. Cronenwett, MD Medical Director, Society for Vascular

More information

TRUFILL DCS ORBIT Detachable Coil System

TRUFILL DCS ORBIT Detachable Coil System ORBIT Conforming to Your Complex Needs Excellent Conformability and Concentric Filling for Outstanding Packing Density ORBIT Full range of Mini Complex and new Tight Distal Loop Technology coils Our Complex

More information

Graft infection after endovascular abdominal aortic aneurysm repair

Graft infection after endovascular abdominal aortic aneurysm repair From the Midwestern Vascular Surgical Society Graft infection after endovascular abdominal aortic aneurysm repair Adriana Laser, MD, a Nichole Baker, RVT, a John Rectenwald, MD, a Jon L. Eliason, MD, a

More information

ALLODERM SELECT ALLODERM SELECT RESTORE

ALLODERM SELECT ALLODERM SELECT RESTORE ALLODERM SELECT ALLODERM SELECT RESTORE Regenerative Tissue Matrix Instructions for Use Processed from donated human tissue by: LifeCell Corporation One Millennium Way Branchburg, NJ 08876-3876 DESCRIPTION

More information

A preliminary study of prosthesis damage by laser energy. James M. Seeger, M.D., George S. Abela, M.D.,* and Nina Klingman, B.S., Gainesville, Fla.

A preliminary study of prosthesis damage by laser energy. James M. Seeger, M.D., George S. Abela, M.D.,* and Nina Klingman, B.S., Gainesville, Fla. Laser radiation in the graft stenosis treatment of prosthetic A preliminary study of prosthesis damage by laser energy James M. Seeger, M.D., George S. Abela, M.D.,* and Nina Klingman, B.S., Gainesville,

More information

Verification of Disk Diffusion Tests

Verification of Disk Diffusion Tests Verification of Disk Diffusion Tests Objectives 1. Describe disk diffusion tests 2. Describe process of FDA clearance of susceptibility tests 3. Discuss CLIA requirements for laboratory verification of

More information

How we deal with aortic endograft infection. Elena Iborra, Emma Espinar, Ramon Vila Hospital Universitari de Bellvitge Barcelona, Spain

How we deal with aortic endograft infection. Elena Iborra, Emma Espinar, Ramon Vila Hospital Universitari de Bellvitge Barcelona, Spain How we deal with aortic endograft infection Elena Iborra, Emma Espinar, Ramon Vila Hospital Universitari de Bellvitge Barcelona, Spain Disclosure Speaker name: Elena Iborra Ortega I have the following

More information

First Experiences with the Ziehm Vision FD Mobile C-Arm with Flat-Panel Detector

First Experiences with the Ziehm Vision FD Mobile C-Arm with Flat-Panel Detector 01 White Paper No. 02/2009 First Experiences with the Ziehm Vision FD Mobile C-Arm with Flat-Panel Detector Leiden University Medical Center (LUMC) in the Netherlands is the first hospital in the world

More information

Division of Dockets Management (HFA 305) U.S. Food and Drug Administration 5630 Fishers Lane Room 1061 Rockville, MD 20852

Division of Dockets Management (HFA 305) U.S. Food and Drug Administration 5630 Fishers Lane Room 1061 Rockville, MD 20852 May 24, 2012 Division of Dockets Management (HFA 305) U.S. Food and Drug Administration 5630 Fishers Lane Room 1061 Rockville, MD 20852 Re: Comments on Docket #FDA- 2012 D 0148; Draft Guidance for Industry

More information

PREVELEAK Surgical sealant

PREVELEAK Surgical sealant PREVELEAK Surgical sealant Rx only Instructions for Use DEVICE DESCRIPTION PREVELEAK Surgical sealant (PREVELEAK) is a sealant developed to seal suture holes formed during surgical repair of the circulatory

More information

Report on New Patented Drugs - Invanz

Report on New Patented Drugs - Invanz Report on New Patented Drugs - Invanz October 2006 Under its transparency initiative, the PMPRB publishes the results of the reviews of new patented drugs by Board Staff, for purposes of applying the PMPRB

More information

Physiopathologie des infections. liées aux cathéters centraux

Physiopathologie des infections. liées aux cathéters centraux Physiopathologie des infections liées aux cathéters centraux David Lebeaux Table ronde - JPP Samedi 8 octobre 2016 Unité de Génétique des biofilms Jean-Marc GHIGO Christophe BELOIN Unité Mobile de Microbiologie

More information

Policies Concerning Survival Surgery of Mice

Policies Concerning Survival Surgery of Mice Policies Concerning Survival Surgery of Mice Date approved: October 25, 2016 Purpose This document details the minimum standards for survival (recovery) surgery in all laboratory rodent species. Responsibility

More information

Received 26 February 1997/Returned for modification 16 September 1997/Accepted 10 February 1998

Received 26 February 1997/Returned for modification 16 September 1997/Accepted 10 February 1998 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, May 1998, p. 1093 1097 Vol. 42, No. 5 0066-4804/98/$04.00 0 Copyright 1998, American Society for Microbiology Comparison of Concentrations of -Ampicillin Administered

More information

Histoacryl A revolution in mesh fixation

Histoacryl A revolution in mesh fixation Histoacryl A revolution in mesh fixation Closure Technologies Histoacryl A revolution in mesh fixation A new indication for a classic product Histoacryl has been used for more than 40 years in operating

More information

The Lancet Publishes Results from the Landmark Phase III Rivaroxaban Study RECORD2

The Lancet Publishes Results from the Landmark Phase III Rivaroxaban Study RECORD2 News Release Bayer HealthCare AG Corporate Communications 51368 Leverkusen Germany Phone +49 214 30 1 www.news.bayer.com Venous Blood Clot Prevention after Hip Replacement Surgery: The Lancet Publishes

More information

High 18 F-FDG Uptake in Synthetic Aortic Vascular Grafts on PET/CT in Symptomatic and Asymptomatic Patients

High 18 F-FDG Uptake in Synthetic Aortic Vascular Grafts on PET/CT in Symptomatic and Asymptomatic Patients High F-FDG Uptake in Synthetic Aortic Vascular Grafts on PET/CT in Symptomatic and Asymptomatic Patients Johan Wassélius 1,2, Jonas Malmstedt 1,3, Bo Kalin 1,2, Stig Larsson 4,5, Anders Sundin 1,2, Ulf

More information

Heparin Induced Thrombocytopenia. Heparin Induced Thrombocytopenia. Heparin Induced Thrombocytopenia. Temporal Aspects.

Heparin Induced Thrombocytopenia. Heparin Induced Thrombocytopenia. Heparin Induced Thrombocytopenia. Temporal Aspects. Heparin Induced Eric Kraut, MD Professor of Internal Medicine The Ohio State University Medical Center Heparin Induced Heparin induced thrombocytopenia occurs in up to 5 % of patients receiving unfractionated

More information

Polymicrobial Infection in Mice

Polymicrobial Infection in Mice ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, JUlY 1993, P. 1531-1535 0066-4804/93/071531-05$02.00/0 Copyright 1993, American Society for Microbiology Vol. 37, No. 7 Use of Cephalosporins for Prophylaxis and

More information

North Carolina Medicaid Special Bulletin

North Carolina Medicaid Special Bulletin North Carolina Medicaid Special Bulletin An Information Service of the Division of Medical Assistance Visit DMA on the Web at http://www.ncdhhs.gov/dma December 2014 Attention: All Providers Modifier 59

More information

BAXTER UNVEILS DESIGN ENHANCEMENTS TO FLOSEAL AND TISSEEL HEMOSTATIC AGENTS AT AORN MEETING

BAXTER UNVEILS DESIGN ENHANCEMENTS TO FLOSEAL AND TISSEEL HEMOSTATIC AGENTS AT AORN MEETING FOR IMMEDIATE RELEASE Media Contact Beth Mueller, (224) 948-5353 media@baxter.com Investor Contact Clare Trachtman, (224) 948-3085 BAXTER UNVEILS DESIGN ENHANCEMENTS TO FLOSEAL AND TISSEEL HEMOSTATIC AGENTS

More information

Development of non-substantially manipulated cell-based ATMPs 1 : flexibility introduced via the application of the risk-based approach

Development of non-substantially manipulated cell-based ATMPs 1 : flexibility introduced via the application of the risk-based approach 3 July 2017 EMA/CAT/216556/2017 Inspections, Human Medicines, Pharmacovigilance and Committees Division Development of non-substantially manipulated cell-based ATMPs 1 : flexibility introduced via the

More information

Recommended Agent First alternative for β-lactam allergy Alternative Agents (in order of preference) document β-lactam allergy for SCIP)

Recommended Agent First alternative for β-lactam allergy Alternative Agents (in order of preference) document β-lactam allergy for SCIP) Surgical Prophylaxis Guideline Updates Wadley Regional Medical Center Surgery and Trauma Committee, July 22, 2014 Pharmacy and Therapeutics Committee, August 2014 Compiled by: Andrea C Jarzyniecki, Pharm

More information

The Clinical Use and Immunologic Impact of Thrombin in Surgery

The Clinical Use and Immunologic Impact of Thrombin in Surgery The Clinical Use and Immunologic Impact of Thrombin in Surgery Jeffrey H. Lawson, M.D., Ph.D. Departments of Surgery and Pathology Duke University Medical Center Durham, North Carolina Bovine Thrombin

More information

Evaluation of Use of a New Chromogenic Agar in Detection of Urinary Tract Pathogens

Evaluation of Use of a New Chromogenic Agar in Detection of Urinary Tract Pathogens JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 1998, p. 990 994 Vol. 36, No. 4 0095-1137/98/$04.00 0 Copyright 1998, American Society for Microbiology Evaluation of Use of a New Chromogenic Agar in Detection of

More information

Thoracoscopic Pneumonectomy. 10 th Annual Masters in Minimally Invasive Thoracic Surgery

Thoracoscopic Pneumonectomy. 10 th Annual Masters in Minimally Invasive Thoracic Surgery Thoracoscopic Pneumonectomy 10 th Annual Masters in Minimally Invasive Thoracic Surgery September 22-23, 2017 Thomas A. D Amico MD Gary Hock Professor of Surgery Section Chief, Thoracic Surgery, Duke University

More information

Regulatory hurdles and opportunities

Regulatory hurdles and opportunities Regulatory hurdles and opportunities Professor Roger Finch Nottingham University Hospitals & University of Nottingham, UK Drug licensing and regulation Mandatory for market authorisation Supports the public

More information

Daily minimum Daily minimum. FiO What if the settings were as follows?

Daily minimum Daily minimum. FiO What if the settings were as follows? Ventilator - Associated Event Case Studies Cindy Gross, MT, SM (ASCP), CIC Division of Healthcare Quality Promotion Centers for Disease Control and Prevention October 4, 2012 The following examples are

More information

TRELLIS COLLAGEN RIBBON

TRELLIS COLLAGEN RIBBON TRELLIS COLLAGEN RIBBON 147321-1 English (en) The following languages are included in this packet: M Wright Medical Technology, Inc. 5677 Airline Rd. Arlington, TN 38002 USA www.wmt.com August 2012 Printed

More information

Investigator Guide Reporting of Unanticipated Problems to the IRB

Investigator Guide Reporting of Unanticipated Problems to the IRB Committee for Protection of Human Subjects The IRB for New York Medical College, Westchester Medical Center, Metropolitan Hospital Center (HHC), and Westchester Institute for Human Development, Terence

More information

Verification of Gradient Diffusion Strips

Verification of Gradient Diffusion Strips Verification of Gradient Diffusion Strips Objectives 1. Describe gradient diffusion tests 2. Describe process of FDA clearance of susceptibility tests 3. Discuss CLIA requirements for laboratory verification

More information

10/2/2016. Control of Microbial Growth. Method. Terminology. Disinfectants and Antiseptics

10/2/2016. Control of Microbial Growth. Method. Terminology. Disinfectants and Antiseptics Control of Microbial Growth Disinfectants and Antiseptics 1 Method Three approaches for the control of microbial growth Chemical Disinfectants and antiseptics Physical Heat Ultraviolet Irradiations Mechanical

More information

FOCUS ON MRSA/SA SSTI ASSAY FAILURE IN PROSTHETIC JOINT. Institute of Microbiology, Lille University Hospital, F Lille, France

FOCUS ON MRSA/SA SSTI ASSAY FAILURE IN PROSTHETIC JOINT. Institute of Microbiology, Lille University Hospital, F Lille, France JCM Accepted Manuscript Posted Online 16 November 2016 J. Clin. Microbiol. doi:10.1128/jcm.01658-16 Copyright 2016, American Society for Microbiology. All Rights Reserved. FOCUS ON MRSA/SA SSTI ASSAY FAILURE

More information

Shionogi Presents Results of the First Clinical Efficacy Trial and In Vitro Data on Cefiderocol (S ), a Siderophore Cephalosporin

Shionogi Presents Results of the First Clinical Efficacy Trial and In Vitro Data on Cefiderocol (S ), a Siderophore Cephalosporin Shionogi Presents Results of the First Clinical Efficacy Trial and In Vitro Data on Cefiderocol (S-649266), a Siderophore Cephalosporin Osaka, Japan, April 22, 2017 - Shionogi & Co., Ltd. today announced

More information

6/28/2016. Control of Microbial Growth. Method. Terminology. Disinfectants and Antiseptics

6/28/2016. Control of Microbial Growth. Method. Terminology. Disinfectants and Antiseptics Control of Microbial Growth Disinfectants and Antiseptics 1 Method Three approaches for the control of microbial growth Chemical Disinfectants and antiseptics Physical Heat Ultraviolet Irradiations Mechanical

More information

Presenting SURGICEL Powder

Presenting SURGICEL Powder SURGICEL Powder Presenting SURGICEL Powder Built to stop continuous, broad-surface oozing fast1,2 The next generation of SURGICEL Absorbable Hemostats SURGICEL Powder efficiently and effectively controls

More information

PLTW Biomedical Science Medical Interventions Course Outline

PLTW Biomedical Science Medical Interventions Course Outline Follow the fictitious Smith family as you learn about the prevention, diagnosis, and treatment of disease. Play the role of biomedical professionals to analyze case information and diagnose and treat your

More information

Novel BioResorbable Vascular Platforms from India

Novel BioResorbable Vascular Platforms from India DEEP DIVE SESSION: Lower limb interventions (part II) Femoropopliteal, drug-eluting devices, and new technologies Time 11:55am to 12:01pm Novel BioResorbable Vascular Platforms from India Dr. Vimal Someshwar

More information

Guidelines for Laboratory Verification of Performance of the FilmArray Blood Culture Identification (BCID) Panel

Guidelines for Laboratory Verification of Performance of the FilmArray Blood Culture Identification (BCID) Panel Guidelines for Laboratory Verification of Performance of the FilmArray Blood Culture Identification (BCID) Panel Purpose The Clinical Laboratory Improvement Amendments (CLIA), passed in 1988, establishes

More information

Use of Heparin and The Related Incidence of Heparin- Induced Thrombocytopenia in an Education and Research Hospital in Turkey

Use of Heparin and The Related Incidence of Heparin- Induced Thrombocytopenia in an Education and Research Hospital in Turkey VOLUME 8 NUMBER 3 September 2017 JOURNAL OF CLINICAL AND EXPERIMENTAL INVESTIGATIONS ORIGINAL ARTICLE Use of Heparin and The Related Incidence of Heparin- Induced Thrombocytopenia in an Education and Research

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #21 (NQF 0268): Perioperative Care: Selection of Prophylactic Antibiotic First OR Second Generation Cephalosporin National Quality Strategy Domain: Patient Safety 2018 OPTIONS FOR INDIVIDUAL

More information

Protect the Neck. Lieven Maene, MD. Marc Bosiers Koen Deloose Joren Callaert. Patrick Peeters Jürgen Verbist. Lieven Maene Roel Beelen.

Protect the Neck. Lieven Maene, MD. Marc Bosiers Koen Deloose Joren Callaert. Patrick Peeters Jürgen Verbist. Lieven Maene Roel Beelen. A.Z. Sint-Blasius, Dendermonde Marc Bosiers Koen Deloose Joren Callaert Imelda Hospital, Bonheiden Protect the Neck Patrick Peeters Jürgen Verbist OLV Hospital, Aalst Lieven Maene Roel Beelen R.Z. Heilig

More information

Microbicidal Properties of a Silver-Containing Hydrofiber Dressing Against a Variety of Burn Wound Pathogens

Microbicidal Properties of a Silver-Containing Hydrofiber Dressing Against a Variety of Burn Wound Pathogens Microbicidal Properties of a Silver-Containing Hydrofiber Dressing Against a Variety of Burn Wound Pathogens P. G. Bowler, MPhil, S. A. Jones, BSc, M. Walker, PhD, D. Parsons, PhD Partial-thickness burns

More information

Optimized Pathogen Detection with 30- Compared to 20-Milliliter Blood Culture Draws

Optimized Pathogen Detection with 30- Compared to 20-Milliliter Blood Culture Draws JOURNAL OF CLINICAL MICROBIOLOGY, Dec. 2011, p. 4047 4051 Vol. 49, No. 12 0095-1137/11/$12.00 doi:10.1128/jcm.01314-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. Optimized

More information

THE INADEQUACY OF PASSIVE SURVEILLANCE TO DETECT SEPTIC TRANSFUSION REACTIONS FROM PLATELET TRANSFUSION

THE INADEQUACY OF PASSIVE SURVEILLANCE TO DETECT SEPTIC TRANSFUSION REACTIONS FROM PLATELET TRANSFUSION THE INADEQUACY OF PASSIVE SURVEILLANCE TO DETECT SEPTIC TRANSFUSION REACTIONS FROM PLATELET TRANSFUSION Septic transfusion reactions resulting from the transfusion of bacterially contaminated platelet

More information

Clinical Applications. ImagingRite. Neuro Intervention. 1 ImagingRite

Clinical Applications. ImagingRite. Neuro Intervention. 1 ImagingRite Clinical Applications ImagingRite Neuro Intervention 1 ImagingRite ImagingRite, a comprehensive suite of imaging tools offered with Infinix -i angiographic systems, was designed to assist clinicians in

More information

NIH Public Access Author Manuscript J Antimicrob Chemother. Author manuscript; available in PMC 2007 November 14.

NIH Public Access Author Manuscript J Antimicrob Chemother. Author manuscript; available in PMC 2007 November 14. NIH Public Access Author Manuscript Published in final edited form as: J Antimicrob Chemother. 2005 August ; 56(2): 413 415. Colicins prevent colonization of urinary catheters Barbara W. Trautner 1,3,5,*,

More information

Published 13 June 2011 Page May 2011

Published 13 June 2011 Page May 2011 filgrastim, 30 million units (300 micrograms)/0.5ml, 48 million units (480 micrograms)/0.5ml, solution for injection or infusion in pre-filled syringe (Zarzio ) SMC No. (704/11) Sandoz Ltd 06 May 2011

More information

Anti- THrombosis with Enoxaparin in intubated Adolescents

Anti- THrombosis with Enoxaparin in intubated Adolescents Anti- THrombosis with Enoxaparin in intubated Adolescents E. Vincent S. Faustino, MD, MHS October 2017 NHLBI submission S L I D E 0 Research question, central hypothesis and primary aim Research Question

More information

Office for Human Subject Protection. University of Rochester

Office for Human Subject Protection. University of Rochester POLICY 1. Purpose Outline the responsibilities and regulatory requirements when conducting human subject research that involves the use of drugs, agents, biological products, or nutritional products (e.g.,

More information

Assembly Biosciences Jefferies 2015 Microbiome Summit. December 16, 2015

Assembly Biosciences Jefferies 2015 Microbiome Summit. December 16, 2015 Assembly Biosciences Jefferies 2015 Microbiome Summit December 16, 2015 Forward-Looking Statements This presentation contains forward-looking statements regarding future events. Forward-looking statements

More information

CAUTION: U.S. Federal law restricts this device to sale by or on the order of a licensed physician.

CAUTION: U.S. Federal law restricts this device to sale by or on the order of a licensed physician. TM CAUTION: U.S. Federal law restricts this device to sale by or on the order of a licensed physician. TABLE OF CONTENTS Section Port Styles 4 Description 5 Indications 5 Contraindications 5-6 Information

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) European Medicines Agency Evaluation of Medicines for Human Use London, 29 July 2004 CPMP/BPWG/1089/00 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE CLINICAL INVESTIGATION OF PLASMA

More information

Antifungal PK/PD Made Simple. David Andes, MD University of Wisconsin

Antifungal PK/PD Made Simple. David Andes, MD University of Wisconsin Antifungal PK/PD Made Simple David Andes, MD University of Wisconsin PK/PD Concept Serum Drug Concentration Peak:MIC AUC:MIC Ratio Time Above MIC MIC Time Hypothesis and Concept There is an optimal drug

More information

Content on this page requires a newer version of Adobe Flash Player.

Content on this page requires a newer version of Adobe Flash Player. Content on this page requires a newer version of Adobe Flash Player. 13-1-2018 IV vesicants and pain while a vesicant will cause tissue damage if it escapes. Ciprofloxacin is not designated as a vesicant

More information

KEY TO INNOVATION AT VASCUTEK JAPAN MATTERS FEBRUARY 7TH 2014

KEY TO INNOVATION AT VASCUTEK JAPAN MATTERS FEBRUARY 7TH 2014 KEY TO INNOVATION AT VASCUTEK JAPAN MATTERS FEBRUARY 7TH 2014 VASCUTEK LTD : Background Manufacturer of synthetic vascular grafts In business since 1982 Over 500 employees Turnover around 70 million No.

More information

SKIN INFECTION OF RABBITS WITH HEMOLYTIC STREP- TOCOCCI ISOLATED FROM A PATIENT WITH ERYSIPELAS.

SKIN INFECTION OF RABBITS WITH HEMOLYTIC STREP- TOCOCCI ISOLATED FROM A PATIENT WITH ERYSIPELAS. SKIN INFECTION OF RABBITS WITH HEMOLYTIC STREP- TOCOCCI ISOLATED FROM A PATIENT WITH ERYSIPELAS. I. METHOD OF DEMONSTRATING PROTECTIVE ACTION OF IMMUNE SERA. BY THOMAS M. RIVERS, M.D. (From the Hospital

More information

Penicillin. Introduction:

Penicillin. Introduction: Penicillin Introduction: Penicillin is a group of antibiotics derived from Penicillium fungi.penicillin antibiotics are historically significant because they were the first drugs that were effective against

More information

Prediction of altered endograft path during endovascular abdominal aortic aneurysm repair with the Gore Excluder

Prediction of altered endograft path during endovascular abdominal aortic aneurysm repair with the Gore Excluder From the New England Society for Vascular Surgery Prediction of altered endograft path during endovascular abdominal aortic aneurysm repair with the Gore Excluder David R. Whittaker, MD, Jeff Dwyer, BA,

More information

Reducing SSI s Through Improved Environmental Hygiene- A Threshold ROI Analysis

Reducing SSI s Through Improved Environmental Hygiene- A Threshold ROI Analysis Reducing SSI s Through Improved Environmental Hygiene- A Threshold ROI Analysis Executive Summary Faced with the need to reduce healthcare acquired infections (HAIs), providers are using a multi-modal

More information

obtained from the infected and treated tissues, Fleming's2 technic of hemolytic streptococcus B. Immediately following the infection, 1.0 ml.

obtained from the infected and treated tissues, Fleming's2 technic of hemolytic streptococcus B. Immediately following the infection, 1.0 ml. THE SENSITIVITY OF STREPTOCOCCI TO PENICILLIN G AFTER EXPOSURE TO THE ANTIBIOTIC IN VIVO* E. GRUNBERG, C. UNGER, AND D. ELDRIDGE Previous investigations by Grunberg, Schnitzer, and Unger3 on the topical

More information

Platelet Concentrate in Total Knees BIOLOGICS. This brochure is for International use only. It is not for distribution in the United States.

Platelet Concentrate in Total Knees BIOLOGICS. This brochure is for International use only. It is not for distribution in the United States. Platelet Concentrate in Total Knees BIOLOGICS This brochure is for International use only. It is not for distribution in the United States. Platelet Concentrate in Total Knees Total Knee Arthroplasty Total

More information

Coordinated Primary Options Service. DVT Management Plan. Management options using Dabigatran or Warfarin

Coordinated Primary Options Service. DVT Management Plan. Management options using Dabigatran or Warfarin Coordinated Primary Options Service DVT Management Plan Management options using Dabigatran or Warfarin Name NHI DOB Ethnicity Gender Address Contact Information Mobile Home Treatment commenced date *CPO

More information

Diagnosis for Open Wounds as a Result of Cancer Resection

Diagnosis for Open Wounds as a Result of Cancer Resection Diagnosis for Open Wounds as a Result of Cancer Resection December 15, 2016 What diagnosis code do we use when we are reconstructing a defect after the Moh s surgeon, or someone else removed the cancer?

More information

GenMark Diagnostics TRANSFORMING MULTIPLEX MOLECULAR TESTING. J.P. Morgan Healthcare Conference 2018

GenMark Diagnostics TRANSFORMING MULTIPLEX MOLECULAR TESTING. J.P. Morgan Healthcare Conference 2018 GenMark Diagnostics TRANSFORMING MULTIPLEX MOLECULAR TESTING J.P. Morgan Healthcare Conference 2018 1 Forward-Looking Statements This presentation contains forward-looking statements about GenMark Diagnostics,

More information

MDR ID: Definition: Applicable:

MDR ID: Definition: Applicable: MDR Classification: (Reference Medical Device Regulation EU 2017/745, Annex VIII) Product: Product Name 1. DURATION OF USE MDR ID: Definition: Applicable: - Invasive Device: Continue Go to 2. Invasive

More information

Immobilization and Death of Bacteria by Flora Seal Microbial Sealant

Immobilization and Death of Bacteria by Flora Seal Microbial Sealant International Journal of Pharmaceutical Science Invention ISSN (Online): 2319 6718, ISSN (Print): 2319 670X Volume 6 Issue 6 June 2017 PP. 45-49 Immobilization and Death of Bacteria by Flora Seal Microbial

More information

Physician Orders - Adult

Physician Orders - Adult Physician Orders - Adult attach patient label here Title: Direct Thrombin Inhibitor (DTI) Protocol Orders Height: cm Weight: kg Allergies: [ ] No known allergies [ ]Medication allergy(s): [ ] Latex allergy

More information

Reliability of 1-3-β-D-glucan monitoring during treatment of peritoneal candidiasis in a child in. continuous peritoneal dialysis: a case report

Reliability of 1-3-β-D-glucan monitoring during treatment of peritoneal candidiasis in a child in. continuous peritoneal dialysis: a case report CVI Accepts, published online ahead of print on 22 February 2012 Clin. Vaccine Immunol. doi:10.1128/cvi.00008-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 Reliability

More information

Microbiology, Biofilms and Factors affecting Wound Healing. Professor Val Edwards-Jones Director of Research Manchester Metropolitan University

Microbiology, Biofilms and Factors affecting Wound Healing. Professor Val Edwards-Jones Director of Research Manchester Metropolitan University Microbiology, Biofilms and Factors affecting Wound Healing Professor Val Edwards-Jones Director of Research Manchester Metropolitan University Lecture overview Types of chronic wounds New techniques Typical

More information

ABC. Methods for Determining Bactericidal Activity of Antimicrobial Agents; Approved Guideline. Volume 19 Number 18

ABC. Methods for Determining Bactericidal Activity of Antimicrobial Agents; Approved Guideline. Volume 19 Number 18 M26-A ISBN 1-56238-384-1 September 1999 ISSN 0273-3099 Methods for Determining Bactericidal Activity of Antimicrobial Agents; Approved Guideline Volume 19 Number 18 Arthur L. Barry, Ph.D. William A. Craig,

More information

Contains Nonbinding Recommendations Draft - Not for Implementation

Contains Nonbinding Recommendations Draft - Not for Implementation Reprinted from FDA s website by EAS Consulting Group, LLC Select Updates for Non-Clinical Engineering Tests and Recommended Labeling for Intravascular Stents and Associated Delivery Systems Draft Guidance

More information

RADIATION EXPOSURE IN ENDOVASCULAR PROCEDURES - AN ASSESSMENT BASED ON EXAMINATIONS PERFORMED AT SAHLGRENSKA UNIVERSITY HOSPITAL

RADIATION EXPOSURE IN ENDOVASCULAR PROCEDURES - AN ASSESSMENT BASED ON EXAMINATIONS PERFORMED AT SAHLGRENSKA UNIVERSITY HOSPITAL SAHLGRENSKA ACADEMY DEPARTMENT OF RADIATION PHYSICS RADIATION EXPOSURE IN ENDOVASCULAR PROCEDURES - AN ASSESSMENT BASED ON EXAMINATIONS PERFORMED AT SAHLGRENSKA UNIVERSITY HOSPITAL M.Sc. thesis Roham D.

More information

Antimicrobial Surfaces to Prevent Healthcare-Associated Infection

Antimicrobial Surfaces to Prevent Healthcare-Associated Infection Antimicrobial Surfaces to Prevent Healthcare-Associated Infection Matthew P. Muller, MD, PhD, FRCPC Medical Director, Infection Prevention and Control, St. Michael s Hospital Chair, Provincial Infectious

More information

Comparison between IRIS iq 200ELITE and microscopy for urinalysis and evaluation of performance in predicting outcome of urine cultures

Comparison between IRIS iq 200ELITE and microscopy for urinalysis and evaluation of performance in predicting outcome of urine cultures Article Reprint Comparison between IRIS iq 200ELITE and microscopy for urinalysis and evaluation of performance in predicting outcome of urine cultures S. Ledru, J.P. Canonne Laboratoire de microbiologie,

More information

Repliform. Tissue Regeneration Matrix. Instructions for Use. Distributed by:

Repliform. Tissue Regeneration Matrix. Instructions for Use. Distributed by: Repliform Tissue Regeneration Matrix Instructions for Use Distributed by: Boston Scientific Corporation 300 Boston Scientific Way Marlborough, MA 01752 Processed from Donated Human Tissue by: LifeCell

More information

Soft Tissue Retaining Set

Soft Tissue Retaining Set U.S. Toll Free 866-GOLIMBS Laparoscopic Surgery Soft Tissue Retaining Set Part No: 50151 For securing synthetic soft tissue components used in intermediate surgical training and laparoscopic trainers.

More information

EVAR Guided by 3D Image Fusion and CO 2 DSA: A New Imaging Combination for Patients With Renal Insufficiency

EVAR Guided by 3D Image Fusion and CO 2 DSA: A New Imaging Combination for Patients With Renal Insufficiency 605468JETXXX10.1177/1526602815605468Journal of Endovascular TherapyKoutouzi et al research-article2015 Technical Note EVAR Guided by 3D Image Fusion and CO 2 DSA: A New Imaging Combination for Patients

More information

R/F. Experiences Using SONIALVISION safire and the Utility of Tomosynthesis. 1. Introduction. 2. Basics of Tomosynthesis.

R/F. Experiences Using SONIALVISION safire and the Utility of Tomosynthesis. 1. Introduction. 2. Basics of Tomosynthesis. R/F Experiences Using SONIALVISION safire and the Utility of Tomosynthesis Radiology Division, Dokkyo Medical University Koshigaya Hospital Masahiro Nakajima Mr. Masahiro Nakajima 1. Introduction The hospital

More information

Optimizing the Use of Pulsed Fluoroscopy to Reduce Radiation Exposure to Children

Optimizing the Use of Pulsed Fluoroscopy to Reduce Radiation Exposure to Children Optimizing the Use of Pulsed Fluoroscopy to Reduce Radiation Exposure to Children Mervyn D. Cohen, MB, ChB, MD Radiologists desire to keep radiation dose as low as possible. Pulsed fluoroscopy provides

More information

Effects of Antibiotic Treatment on the Results of Nested ACCEPTED. Polymerase Chain Reactions for Scrub Typhus

Effects of Antibiotic Treatment on the Results of Nested ACCEPTED. Polymerase Chain Reactions for Scrub Typhus JCM Accepts, published online ahead of print on 0 August 00 J. Clin. Microbiol. doi:0./jcm.00-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

More information